全文获取类型
收费全文 | 1167篇 |
免费 | 57篇 |
国内免费 | 56篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 69篇 |
妇产科学 | 10篇 |
基础医学 | 135篇 |
口腔科学 | 24篇 |
临床医学 | 145篇 |
内科学 | 269篇 |
皮肤病学 | 51篇 |
神经病学 | 31篇 |
特种医学 | 298篇 |
外科学 | 53篇 |
综合类 | 24篇 |
预防医学 | 39篇 |
眼科学 | 5篇 |
药学 | 67篇 |
中国医学 | 2篇 |
肿瘤学 | 57篇 |
出版年
2023年 | 4篇 |
2021年 | 11篇 |
2020年 | 9篇 |
2019年 | 8篇 |
2018年 | 17篇 |
2017年 | 6篇 |
2016年 | 6篇 |
2015年 | 13篇 |
2014年 | 13篇 |
2013年 | 39篇 |
2012年 | 22篇 |
2011年 | 14篇 |
2010年 | 35篇 |
2009年 | 56篇 |
2008年 | 20篇 |
2007年 | 57篇 |
2006年 | 25篇 |
2005年 | 22篇 |
2004年 | 16篇 |
2003年 | 15篇 |
2002年 | 17篇 |
2001年 | 15篇 |
2000年 | 15篇 |
1999年 | 23篇 |
1998年 | 71篇 |
1997年 | 80篇 |
1996年 | 101篇 |
1995年 | 61篇 |
1994年 | 58篇 |
1993年 | 52篇 |
1992年 | 17篇 |
1991年 | 20篇 |
1990年 | 23篇 |
1989年 | 38篇 |
1988年 | 37篇 |
1987年 | 34篇 |
1986年 | 45篇 |
1985年 | 40篇 |
1984年 | 8篇 |
1983年 | 14篇 |
1982年 | 13篇 |
1981年 | 9篇 |
1980年 | 12篇 |
1979年 | 8篇 |
1978年 | 12篇 |
1977年 | 10篇 |
1976年 | 15篇 |
1975年 | 13篇 |
1974年 | 3篇 |
1973年 | 3篇 |
排序方式: 共有1280条查询结果,搜索用时 15 毫秒
1.
2.
Y. Le Meur M. Büchler A. Thierry S. Caillard F. Villemain S. Lavaud I. Etienne P.-F. Westeel B. H. de Ligny L. Rostaing E. Thervet J. C. Szelag J.-P. Rérolle A. Rousseau G. Touchard P. Marquet 《American journal of transplantation》2007,7(11):2496-2503
Efficacy and safety of mycophenolate mofetil (MMF) may be optimized with individualized doses based on therapeutic monitoring of its active metabolite, mycophenolic acid (MPA). In this 12-month study, 137 renal allograft recipients from 11 French centers receiving basiliximab, cyclosporine A, MMF and corticosteroids were randomized to receive either concentration-controlled doses or fixed-dose MMF. A novel Bayesian estimator of MPA AUC based on three-point sampling was used to individualize doses on posttransplant days 7 and 14 and months 1, 3 and 6. The primary endpoint was treatment failure (death, graft loss, acute rejection and MMF discontinuation). Data from 65 patients/group were analyzed. At month 12, the concentration-controlled group had fewer treatment failures (p = 0.03) and acute rejection episodes (p = 0.01) with no differences in adverse event frequency. The MMF dose was higher in the concentration-controlled group at day 14 (p < 0.0001), month 1 (p < 0.0001) and month 3 (p < 0.01), as were median AUCs on day 14 (33.7 vs. 27.1 mg*h/L; p = 0.0001) and at month 1 (45.0 vs. 30.9 mg*h/L; p < 0.0001). Therapeutic MPA monitoring using a limited sampling strategy can reduce the risk of treatment failure and acute rejection in renal allograft recipients 12 months posttransplant with no increase in adverse events. 相似文献
3.
4.
5.
6.
Leonidas JC; Berdon WE; Valderrama E; Neveling U; Schuval S; Weiss SJ; Hilfer C; Godine L 《Radiology》1996,198(2):377
7.
JC Sitek† M Loeb‡ JR Ronnevig¶ 《Journal of the European Academy of Dermatology and Venereology》2007,21(7):891-896
BACKGROUND: Since 1997, a number of trials have shown promising results in treating generalized vitiligo with narrowband ultraviolet B (UVB) both in adults and children. However, there is little knowledge concerning the duration and permanency of the treatment-induced repigmentation. OBJECTIVE: Our main objective was to perform a follow-up trial of successfully treated patients receiving narrowband UVB for generalized vitiligo. METHODS: We have investigated to what degree the treatment-induced repigmentation remains stable for up to 2 years post-treatment. We performed an initial open trial including 31 patients with generalized vitiligo. They received narrowband UVB thrice weekly for up to 12 months. Patients experiencing > 75% repigmentation were defined responders and were included in the follow-up trial. Responders were followed every 6 months for up to 2 years after cessation of treatment. We observed the pigmentation status and registered any changes indicating loss of pigmentation and relapse. RESULTS: Eleven of the 31 treated patients were included in the follow-up trial. Six patients had relapse and five patients had stable response 24 months after cessation of treatment. Four out of six relapses were within 6 months post-treatment. CONCLUSION: In our study population of 31 patients with generalized vitiligo, five patients (16%) experienced > 75% stable repigmentation 2 years after cessation of a treatment programme of up to 1 years narrowband UVB therapy. 相似文献
8.
Ongoing pregnancies after intracytoplasmic injection using cryopreserved testicular spermatozoa 总被引:4,自引:2,他引:2
Perraguin-Jayot S; Audebert A; Emperaire JC; Parneix I 《Human reproduction (Oxford, England)》1997,12(12):2706-2709
We report two clinical pregnancies occurring after intracytoplasmic sperm
injection (ICSI) using cryopreserved spermatozoa obtained from testicular
biopsy, made in two different infertility situations in our clinic. The
first patient showed a secretory azoospermia associated with elevated serum
follicular stimulating hormone (FSH) level and spermiogenesis maturation
arrest. The second patient was affected by azoospermia resulting from
bilateral epididymal obstruction. Spermatozoa present in the wet
preparation of testicular biopsy made on the day of scrotal exploration
were cryopreserved within the testicular tissue for both men.
Intracytoplasmic injections were performed at a later date, using
spermatozoa prepared from frozen-thawed tissues. In each case, three
embryos were obtained and transferred in utero. The transfers resulted in a
twin pregnancy for the first case, and in a singleton pregnancy for the
second. Living foetuses were seen in the ultrasound scan at the 7th week
and both pregnancies are proceeding to date beyond 30 weeks without
complications.
相似文献
9.
10.